Deulorlatinib

Deulorlatinib (compound A), a deuterated derivative of Lorlatinib (HY-12215), is a potent inhibitor of tyrosine kinase demonstrating the potential for the research of ALK-positive advanced NSCLC[1][2].

Product Specifications

CAS Number

[2131126-33-3]

UNSPSC

12352005

Target

Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Others

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Smiles

N#CC1=C2C3=CN=C(N)C(O[C@@H](C4=CC(F)=CC=C4C(N(CC2=NN1C([2H])([2H])[2H])C)=O)C)=C3

Molecular Formula

C21H16D3FN6O2

Molecular Weight

409.43

References & Citations

[1]Shenzhen TargetRx, Inc. Process for preparation of macrocycle. World Intellectual Property Organization, WO2017148325 A1 2017-09-08

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-90373AF750 0.1 mL

Rabbit Monoclonal HAI-2/SPINT2 Antibody (001) [Alexa Fluor 750]

Ask

View Details

MBS9629132-01 0.1 mL

RBM24 Antibody

Ask

View Details

MBS9629132-02 0.2 mL

RBM24 Antibody

Ask

View Details

MBS9629132-03 5x 0.2 mL

RBM24 Antibody

Ask

View Details

MBS103825-01 48 Well

Camel Proteasome Subunit Alpha Type 5 ELISA Kit

Ask

View Details

MBS103825-02 96 Well

Camel Proteasome Subunit Alpha Type 5 ELISA Kit

Ask

View Details